Submitted by comunicaciones on Wed, 06/05/2024 - 12:09
ECBE
ECBE Diabetes Mellitus Hospitalario
seccion ECBE
Referencias
Body
  1. World Health Organization. who.int. 2023 [citado 19 de septiembre de 2023]. Diabetes. Disponible en: https://www.who.int/health-topics/diabetes
  2. International Expert Committee Report on the Role of the A1C Assay in the Diagnosis of Diabetes. Diabetes Care. julio de 2009;32(7):1327-34.
  3. Expert Committee on the Diagnosis and Classification of Diabetes Mellitus. Report of the expert committee on the diagnosis and classification of diabetes mellitus. Diabetes Care. enero de 2003;26 Suppl 1:S5-20.
  4. Home, Resources, diabetes L with, Acknowledgement, FAQs, Contact, et al. IDF Diabetes Atlas 2021 | IDF Diabetes Atlas [Internet]. [citado 20 de septiembre de 2023]. Disponible en: https://diabetesatlas.org/atlas/tenth-edition/
  5. Vargas-Uricoechea H, Casas-Figueroa LÁ. Epidemiología de la diabetes mellitus en Sudamérica: la experiencia de Colombia. Clínica E Investig En Arterioscler. 1 de septiembre de 2016;28(5):245-56.
  6. Pratiwi C, Mokoagow MI, Made Kshanti IA, Soewondo P. The risk factors of inpatient hypoglycemia: A systematic review. Heliyon. mayo de 2020;6(5):e03913.
  7. Murad MH, Coburn JA, Coto-Yglesias F, Dzyubak S, Hazem A, Lane MA, et al. Glycemic control in non-critically ill hospitalized patients: a systematic review and meta-analysis. J Clin Endocrinol Metab. enero de 2012;97(1):49-58.
  8. Chaparro-Narváez P, Alvis-Zakzuk NJ, Díaz-Jiménez D, Castañeda-Orjuela C. Trends in diabetes mortality identified from death certificates in Colombia, 1979-2017. Rev Panam Salud Pública. 15 de enero de 2021;45:1.
  9. Gebreegziabher Y, McCullough PA, Bubb C, Loney-Hutchinson L, Makaryus JN, Anand N, et al. Admission hyperglycemia and length of hospital stay in patients with diabetes and heart failure: a prospective cohort study. Congest Heart Fail Greenwich Conn. 2008;14(3):117-20.
  10. Umpierrez GE, Isaacs SD, Bazargan N, You X, Thaler LM, Kitabchi AE. Hyperglycemia: an independent marker of in-hospital mortality in patients with undiagnosed diabetes. J Clin Endocrinol Metab. marzo de 2002;87(3):978-82.
  11. Bruno A, Gregori D, Caropreso A, Lazzarato F, Petrinco M, Pagano E. Normal glucose values are associated with a lower risk of mortality in hospitalized patients. Diabetes Care. noviembre de 2008;31(11):2209-10.
  12. Evans NR, Dhatariya KK. Assessing the relationship between admission glucose levels, subsequent length of hospital stay, readmission and mortality. Clin Med. 1 de abril de 2012;12(2):137-9.
  13. Graveling A, Walden E, Flanagan D, Stanisstreet D. JBDS 01 The Hospital Management of Hypoglycaemia in Adults with Diabetes Mellitus | The Association of British Clinical Diabetologists [Internet]. 2023 [citado 12 de marzo de 2024]. Disponible en: https://abcd.care/resource/current/jbds-01-hospital-management-hypoglycaemia-adults-diabetes-mellitus
  14. Seaquist ER, Anderson J, Childs B, Cryer P, Dagogo-Jack S, Fish L, et al. Hypoglycemia and diabetes: a report of a workgroup of the American Diabetes Association and the Endocrine Society. Diabetes Care. mayo de 2013;36(5):1384-95.
  15. Gianchandani RY, Iyengar JL, Butler SO, Chames MC, Raymond E, Miller BS, et al. Inpatient Diabetes Guideline for Adult Non-Critically Ill Patients [Internet]. Ann Arbor (MI): Michigan Medicine University of Michigan; 2020 [citado 12 de febrero de 2024]. (Michigan Medicine Clinical Care Guidelines). Disponible en: http://www.ncbi.nlm.nih.gov/books/NBK559540/
  16. Korytkowski MT, Muniyappa R, Antinori-Lent K, Donihi AC, Drincic AT, Hirsch IB, et al. Management of Hyperglycemia in Hospitalized Adult Patients in Non-Critical Care Settings: An Endocrine Society Clinical Practice Guideline. J Clin Endocrinol Metab. 1 de agosto de 2022;107(8):2101-28.
  17. Pollock F, Funk DC. Acute diabetes management: adult patients with hyperglycemic crises and hypoglycemia. AACN Adv Crit Care. 2013;24(3):314-24.
  18. Pollock F, Funk DC. Acute diabetes management: adult patients with hyperglycemic crises and hypoglycemia. AACN Adv Crit Care. 2013;24(3):314-24.
  19. Brouwers MC, Kerkvliet K, Spithoff K, Consortium ANS. The AGREE Reporting Checklist: a tool to improve reporting of clinical practice guidelines. BMJ. 8 de marzo de 2016;352:i1152.
  20. Kitabchi AE, Umpierrez GE, Miles JM, Fisher JN. Hyperglycemic crises in adult patients with diabetes. Diabetes Care. julio de 2009;32(7):1335-43.
  21. The Impact of Carbamylation and Anemia on HbA1c’s Association With Renal Outcomes in Patients With Diabetes and Chronic Kidney Disease | Diabetes Care | American Diabetes Association [Internet]. [citado 13 de febrero de 2024]. Disponible en: https://diabetesjournals.org/care/article/46/1/130/147949/The-Impact-of-Carbamylation-and-Anemia-on-HbA1c-s
  22. Gallagher EJ, Le Roith D, Bloomgarden Z. Review of hemoglobin A1c in the management of diabetes. J Diabetes. 2009;1(1):9-17.
  23. Guo W, Zhou Q, Jia Y, Xu J. Increased Levels of Glycated Hemoglobin A1c and Iron Deficiency Anemia: A Review. Med Sci Monit. 7 de noviembre de 2019;25:8371-8.
  24. HbA1c: a review of non-glycaemic variables | Journal of Clinical Pathology [Internet]. [citado 13 de febrero de 2024]. Disponible en: https://jcp.bmj.com/content/72/1/12.long
  25. Barakat S, Habib H, Chun C, Oh E. 130-LB: Linagliptin vs. Sitagliptin for Type 2 Diabetes Inpatient Glycemic Management and Cardiovascular Outcomes—Is There a Difference between DPP-4 Inhibitors? | Diabetes | American Diabetes Association [Internet]. [citado 12 de febrero de 2024]. Disponible en: https://diabetesjournals.org/diabetes/article/71/Supplement_1/130-LB/146731/130-LB-Linagliptin-vs-Sitagliptin-for-Type-2
  26. Glycaemic efficacy and safety of linagliptin for the management of non-cardiac surgery patients with type 2 diabetes in a real-world setting: Lina-Surg study - PubMed [Internet]. [citado 12 de febrero de 2024]. Disponible en: https://pubmed.ncbi.nlm.nih.gov/31037970/
  27. Asakawa M, Mitsui H, Akihisa M, Sekine T, Niitsu Y, Kobayashi A, et al. Efficacy and safety of sitagliptin for the treatment of diabetes mellitus complicated by chronic liver injury. SpringerPlus. 15 de julio de 2015;4:346.
  28. Umpierrez GE, Gianchandani R, Smiley D, Jacobs S, Wesorick DH, Newton C, et al. Safety and efficacy of sitagliptin therapy for the inpatient management of general medicine and surgery patients with type 2 diabetes: a pilot, randomized, controlled study. Diabetes Care. noviembre de 2013;36(11):3430-5.
  29. Ul Amin N, Sabir F, Amin T, Sarfraz Z, Sarfraz A, Robles-Velasco K, et al. SGLT2 Inhibitors in Acute Heart Failure: A Meta-Analysis of Randomized Controlled Trials. Healthc Basel Switz. 23 de noviembre de 2022;10(12):2356.
  30. Talha KM, Anker SD, Butler J. SGLT-2 Inhibitors in Heart Failure: A Review of Current Evidence. Int J Heart Fail. 13 de marzo de 2023;5(2):82-90.
  31. Halvorsen S, Mehilli J, Cassese S, Hall TS, Abdelhamid M, Barbato E, et al. 2022 ESC Guidelines on cardiovascular assessment and management of patients undergoing non-cardiac surgery. Eur Heart J. 14 de octubre de 2022;43(39):3826-924.
  32. Pasquel FJ, Cecilia Lansang M, Dhatariya K, Umpierrez GE. Management of diabetes and hyperglycaemia in the hospital. Lancet Diabetes Endocrinol. marzo de 2021;9(3):174-88.
  33. McCall AL, Lieb DC, Gianchandani R, MacMaster H, Maynard GA, Murad MH, et al. Management of Individuals With Diabetes at High Risk for Hypoglycemia: An Endocrine Society Clinical Practice Guideline. J Clin Endocrinol Metab. 1 de marzo de 2023;108(3):529-62.
  34. Gómez AM, Vallejo S, Ardila F, Muñoz OM, Ruiz ÁJ, Sanabria M, et al. Impact of a Basal-Bolus Insulin Regimen on Metabolic Control and Risk of Hypoglycemia in Patients With Diabetes Undergoing Peritoneal Dialysis. J Diabetes Sci Technol. 20 de septiembre de 2017;12(1):129-35.
  35. Savu O, Elian V, Steriade O, Teodoru I, Mihut S, Tacu C, et al. The impact of basal insulin analogues on glucose variability in patients with type 2 diabetes undergoing renal replacement therapy for end-stage renal disease. Int Urol Nephrol. 1 de febrero de 2016;48(2):265-70.
  36. Diabetes Canada Clinical Practice Guidelines Expert Working Group:, Robinson DJ, Hanson K, Jain AB, Kichler JC, Mehta G, et al. Diabetes and Mental Health. Can J Diabetes. junio de 2023;47(4):308-44.
  37. Price HC, Ismail K, Care the JBDS (JBDS) for I. Royal College of Psychiatrists Liaison Faculty & Joint British Diabetes Societies (JBDS): guidelines for the management of diabetes in adults and children with psychiatric disorders in inpatient settings. Diabet Med. 2018;35(8):997-1004.
  38. Zisman-Ilani Y, Fasing K, Weiner M, Rubin DJ. Exercise capacity is associated with hospital readmission among patients with diabetes. BMJ Open Diabetes Res Care. octubre de 2020;8(1):e001771.
  39. Umpierre D, Ribeiro PAB, Kramer CK, Leitão CB, Zucatti ATN, Azevedo MJ, et al. Physical Activity Advice Only or Structured Exercise Training and Association With HbA1c Levels in Type 2 Diabetes: A Systematic Review and Meta-analysis. JAMA. 4 de mayo de 2011;305(17):1790-9.
  40. Knudsen L, Hansen DL, Joensen LE, Wibaek R, Benros ME, Jørgensen ME, et al. Need for improved diabetes support among people with psychiatric disorders and diabetes treated in psychiatric outpatient clinics: results from a Danish cross-sectional study. BMJ Open Diabetes Res Care. enero de 2022;10(1):e002366.
  41. Agiostratidou G, Anhalt H, Ball D, Blonde L, Gourgari E, Harriman KN, et al. Standardizing Clinically Meaningful Outcome Measures Beyond HbA1c for Type 1 Diabetes: A Consensus Report of the American Association of Clinical Endocrinologists, the American Association of Diabetes Educators, the American Diabetes Association, the Endocrine Society, JDRF International, The Leona M. and Harry B. Helmsley Charitable Trust, the Pediatric Endocrine Society, and the T1D Exchange. Diabetes Care. diciembre de 2017;40(12):1622-30.
  42. American Diabetes Association Professional Practice Committee. 9. Pharmacologic Approaches to Glycemic Treatment: Standards of Care in Diabetes—2024. Diabetes Care. 11 de diciembre de 2023;47(Supplement_1):S158-78.
  43. National Clinical Guideline Centre (UK). Type 1 Diabetes in Adults: Diagnosis and Management [Internet]. London: National Institute for Health and Care Excellence (NICE); 2015 [citado 12 de febrero de 2024]. (National Institute for Health and Care Excellence: Clinical Guidelines). Disponible en: http://www.ncbi.nlm.nih.gov/books/NBK315808/
  44. Gil-Olivares F, Manrique H, Castillo-Bravo L, Perez L, Campomanes G, Aliaga K, et al. Manejo de las crisis glucémicas en pacientes adultos con diabetes mellitus: Guía de Práctica Clínica basada en evidencia, Lima - Perú.: Management of glycemic crises in adult patients with diabetes mellitus: Evidence-based Clinical Practice Guideline, Lima - Peru. Rev Fac Med Humana [Internet]. 6 de enero de 2021 [citado 12 de febrero de 2024];21(1). Disponible en: https://revistas.urp.edu.pe/index.php/RFMH/article/view/3194
  45. Karslioglu French E, Donihi AC, Korytkowski MT. Diabetic ketoacidosis and hyperosmolar hyperglycemic syndrome: review of acute decompensated diabetes in adult patients. BMJ. 29 de mayo de 2019;365:l1114.
  46. Cherpanath TGV, Hirsch A, Geerts BF, Lagrand WK, Leeflang MM, Schultz MJ, et al. Predicting Fluid Responsiveness by Passive Leg Raising: A Systematic Review and Meta-Analysis of 23 Clinical Trials. Crit Care Med. mayo de 2016;44(5):981-91.
  47. Bentzer P, Griesdale DE, Boyd J, MacLean K, Sirounis D, Ayas NT. Will This Hemodynamically Unstable Patient Respond to a Bolus of Intravenous Fluids? JAMA. 27 de septiembre de 2016;316(12):1298-309.
  48. Gow K, Rashidi A, Whithead L. Factors Influencing Medication Adherence Among Adults Living with Diabetes and Comorbidities: a Qualitative Systematic Review. Curr Diab Rep. 1 de febrero de 2024;24(2):19-25.
  49. Dhatariya KK, Joint British Diabetes Societies for Inpatient Care. The management of diabetic ketoacidosis in adults-An updated guideline from the Joint British Diabetes Society for Inpatient Care. Diabet Med J Br Diabet Assoc. junio de 2022;39(6):e14788.
  50. Ilott I, Rick J, Patterson M, Turgoose C, Lacey A. What is protocol-based care? A concept analysis. J Nurs Manag. 2006;14(7):544-52.
  51. Gulwani S. Programming by Examples: Applications, Algorithms, and Ambiguity Resolution.
  52. Dhatariya KK, Glaser NS, Codner E, Umpierrez GE. Diabetic ketoacidosis. Nat Rev Dis Primer. 14 de mayo de 2020;6(1):40.
  53. ElSayed NA, Aleppo G, Aroda VR, Bannuru RR, Brown FM, Bruemmer D, et al. 2. Classification and Diagnosis of Diabetes: Standards of Care in Diabetes—2023. Diabetes Care. 1 de enero de 2023;46(Supplement_1):S19-40.
  54. Jun GT, Ward J, Morris Z, Clarkson J. Health care process modelling: which method when? Int J Qual Health Care. 1 de junio de 2009;21(3):214-24.
  55. Page MJ, McKenzie JE, Bossuyt PM, Boutron I, Hoffmann TC, Mulrow CD, et al. The PRISMA 2020 statement: an updated guideline for reporting systematic reviews | The BMJ [Internet]. [citado 20 de septiembre de 2023]. Disponible en: https://www.bmj.com/content/372/bmj.n71
  56. Raccah D, Huet D, Dib A, Joseph F, Landers B, Escalada J, et al. Review of basal‐plus insulin regimen options for simpler insulin intensification in people with Type 2 diabetes mellitus. Diabet Med. septiembre de 2017;34(9):1193-204.